51.05
1.81%
-0.94
Handel nachbörslich:
51.05
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
0.84%
17.60
|
17.45 | 16.50 | 16.13 | 15.48 |
Cost Of Revenue |
4.24%
4.2104
|
4.0392 | 3.6673 | 3.9439 | 3.7536 |
Gross Profit |
0.19%
13.39
|
13.41 | 12.84 | 12.19 | 11.72 |
Operating Expenses
|
4.68%
8.6394
|
8.2531 | 6.932 | 7.2235 | 7.7142 |
Benefits Costs and Expenses |
4.96%
12.35
|
11.77 | 10.10 | 10.83 | 11.13 |
Costs And Expenses |
4.96%
12.35
|
11.77 | 10.10 | 10.83 | 11.13 |
Operating Income/Loss |
7.97%
4.7483
|
5.1598 | 5.9053 | 4.963 | 4.0072 |
Nonoperating Income/Loss |
5.11%
0.4952
|
0.5218 | 0.5032 | 0.3354 | 0.3424 |
Income/Loss From Continuing Operations Before Tax |
7.71%
5.2435
|
5.6816 | 6.4085 | 5.2984 | 4.3497 |
Income Tax Expense/Benefit |
3.06%
1.107
|
1.142 | 1.3414 | 1.1186 | 0.9436 |
Income/Loss From Continuing Operations After Tax |
8.88%
4.1365
|
4.5397 | 5.0672 | 4.1798 | 3.4061 |
Net Income/Loss
|
8.88%
4.1365
|
4.5397 | 5.0672 | 4.1798 | 3.4061 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
222.13K%
12.66
|
0.0057 | 12.60 | 12.60 | 12.59 |
Diluted Average Shares |
229.96K%
12.75
|
0.00554 | 12.74 | 12.72 | 12.69 |
Basic Earnings Per Share |
8.33%
0.33
|
0.36 | 0.40 | 0.33 | 0.27 |
Diluted Earnings Per Share |
11.11%
0.32
|
0.36 | 0.40 | 0.33 | 0.27 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):